Company intelligence / Profile preview

Hemagen Diagnostics

Columbia, Maryland, USA

Ownership: Private
Employees: ~35
Development stage: Other

Overview

Hemagen Diagnostics was a medical technology company that developed, manufactured, and marketed diagnostic test kits used in clinical laboratories. The company specialized in kits for the detection of autoimmune and infectious diseases, utilizing technologies such as Enzyme-Linked Immunosorbent Assay (ELISA) and Immunofluorescence Assay (IFA). Its primary product line, marketed under the VIRGO brand, included tests for conditions like systemic lupus erythematosus and various viral infections. In 2017, following financial difficulties and a Chapter 11 filing, the company sold substantially all of its assets to Vibrant Sciences.

Therapeutic areas: ImmunologyRheumatologyInfectious Diseases
Modalities: Diagnostic KitELISAIFA
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Hemagen Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemagen Diagnostics.

Explore the full profile